Atezolizumab (Tecentriq)

OFFICE ADMINISTRATION

FDA Approved Indications:
  • Treatment of locally advanced or metastatic urothelial carcinoma in patients who:
    • have disease progression during or following any platinum-containing chemotherapy, or within 12 months of neoadjuvant or adjuvant chemotherapy, OR
    • are not eligible for cisplantin-containing chemotherapy
  • Treatment of metastatic non-small cell lung cancer in patients who have disease progression during or following platinum-containing chemotherapy.  Patients with EGFR or ALK genomic tumor aberrations should have disease progression on FDA-approved therapy for these aberrations prior to receiving Tecentriq
Patients must meet the following criteria for the indications above:
  • Prescribed by an oncologist, AND
  • Patient is at least 18 years of age, AND
  • Chart note documenation confirms above diagnosis, AND
  • For advance or metastic urothelial carcinoma: the patient has disease progression during or following platinum-containing chemotherapy, or within 12 months of neoadjuvant or adjuvant chemotherapy, OR is not eligible for cisplatin-containing chemotherapy
  • For metastic non-small cell lung cancer: the patient has disease progression during or following platinum-containing chemotherapy, AND patients with EGFR or ALK genomic tumor aberrations should have disease progression on FDA-approved therapy for these aberrations prior to starting Tecentriq
Dosing:
  • Administer 1200 mg as an IV infusion over 60 minutes every 3 weeks
Approval:
  • One year

The site you are transferring to is not hosted by WHA. WHA's Terms of Use and internet Privacy Practices do not apply to your use of this linked site. Please review the policies on privacy and terms of use for the linked site. WHA does not control the accuracy, completeness, or timeliness of the content on the linked site.

Press Esc to cancel

El sitio Web al que está siendo transferido no es provisto por WHA. Las Condiciones de Uso y las Prácticas de Privacidad en Internet de WHA no se aplican a este sitio Web asociado que usted está usando. Revise las políticas sobre la privacidad y condiciones de uso de este sitio Web asociado. WHA no tiene control sobre la exactitud, la totalidad o la actualidad del contenido del sitio Web asociado. WHA no puede garantizar que los servicios de traducción de idiomas estarán disponibles en el sitio vinculado.

Presione «Esc» para cancelar